We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Clears AlphaID At Home for Direct-to-Consumer Use
FDA Clears AlphaID At Home for Direct-to-Consumer Use
The FDA has granted Grifols marketing clearance for its AlphaID At Home direct-to-consumer screening test for alpha-1 antitrypsin deficiency, which can cause a hereditary form of emphysyma as well as cirrhosis of the liver.